Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SPHL | Springview | $7.43 | -$9.98 | -57.32% | 4.1M | $87M | $1.92$62.40 |
| ANPA | Rich Sparkle | $99.66 | -$58.23 | -36.88% | 121.5K | $1.2B | $2.80$180.64 |
| MLEC | Moolec Science | $5.05 | -$2.65 | -34.42% | 599.1K | $3.7M | $3.08$157.05 |
| RAYA | Erayak Power Solution Group | $2.77 | -$1.16 | -29.52% | 544.3K | $2.5M | $2.63$737.00 |
| PAVM | PAVmed | $6.58 | -$2.17 | -24.80% | 101.3K | $7.0M | $6.00$26.85 |
| SMCZ | Tidal Trust II - Defiance Daily Target 2x Short Smci ETF | $42.75 | -$12.42 | -22.51% | 653.7K | - | $19.85$225.57 |
| AHMA | Ambitions Enterprise Management L.l.c | $23.31 | -$6.07 | -20.66% | 437.1K | $688M | $4.00$31.07 |
| MFI | mF International | $14.11 | -$2.89 | -17.00% | 27.8K | $708M | $4.08$60.73 |
| MTEX | Mannatech | $7.61 | -$1.52 | -16.67% | 57.3K | $14M | $6.90$16.49 |
| ACCL | Acco Group | $2.50 | -$0.49 | -16.39% | 24.5M | $35M | $2.10$5.00 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
3 Top Stocks Worth Buying for the Long Term in 2023
Michael Byrne|Dec 30, 2022
Opportunities abound as investors close the book on 2022 and turn to 2023.
This Former SPAC Beat the Market in 2022. Is It a Buy for 2023?
Michael Byrne|Dec 23, 2022
This 112-year-old company is growing like it's the next hot start-up.
Advertisement
What's the Outlook for Arbutus Biopharma?
Keith Speights and Brian Orelli, PhD|Feb 5, 2022
The company could have great prospects if its hepatitis B virus therapy is successful in clinical testing.
3 Healthcare Stocks That Rocketed Higher in July
Cory Renauer|Aug 3, 2020
Here's what drove shares of these healthcare stocks through the roof last month.
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
Taylor Carmichael|Jul 24, 2020
The ruling means Moderna may have to pay royalties on its mRNA-based vaccines -- including its coronavirus candidate.
